MSLN and neoplasm: Using a completely different approach, Macura et al. developed porous silica microspheres (Acid-Prepared Mesoporous Silica (APMS)) internally loaded with the chemotherapeutic doxorubicin and functionalized on the surface with anti-mesothelin antibodies for tumor targeting [22].